| Literature DB >> 28528775 |
Yingli Ma1, Yang Yue2, Yanbin Ma1, Qing Zhang1, Qingtong Zhou2, Yunpeng Song1, Yuqing Shen1, Xun Li1, Xiaochuan Ma1, Chao Li3, Michael A Hanson4, Gye Won Han5, E Allen Sickmier6, Gayathri Swaminath7, Suwen Zhao8, Raymond C Stevens8, Liaoyuan A Hu1, Wenge Zhong1, Mingqiang Zhang1, Fei Xu9.
Abstract
Apelin receptor (APJR) is a key regulator of human cardiovascular function and is activated by two different endogenous peptide ligands, apelin and Elabela, each with different isoforms diversified by length and amino acid sequence. Here we report the 2.6-Å resolution crystal structure of human APJR in complex with a designed 17-amino-acid apelin mimetic peptide agonist. The structure reveals that the peptide agonist adopts a lactam constrained curved two-site ligand binding mode. Combined with mutation analysis and molecular dynamics simulations with apelin-13 binding to the wild-type APJR, this structure provides a mechanistic understanding of apelin recognition and binding specificity. Comparison of this structure with that of other peptide receptors suggests that endogenous peptide ligands with a high degree of conformational flexibility may bind and modulate the receptors via a similar two-site binding mechanism.Entities:
Keywords: apelin recognition and binding specificity; cardiovascular drug target; designed agonist peptide mimic; human apelin receptor
Mesh:
Substances:
Year: 2017 PMID: 28528775 DOI: 10.1016/j.str.2017.04.008
Source DB: PubMed Journal: Structure ISSN: 0969-2126 Impact factor: 5.006